CompletedPhase 4NCT06184438

Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment in Anal Fistula Surgery

Studying Anal fistula

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Taipei Medical University Shuang Ho Hospital
Principal Investigator
Tungcheng Chang, MD, PHD
Taipei Medical University Shuang Ho Hospital
Intervention
Micronized purified flavonoid fraction(Daflon 1000mg)(drug)
Enrollment
106 enrolled
Eligibility
20-85 years · All sexes
Timeline
2023 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06184438 on ClinicalTrials.gov

Other trials for Anal fistula

Additional recruiting or active studies for the same condition.

See all trials for Anal fistula →

← Back to all trials